MicroRNAs-A Promising Tool for Asthma Diagnosis and Severity Assessment: A Systematic Review

Micro RNAs (miRNAs) are short, non-coding RNAs (Ribonucleic acids) with regulatory functions that could prove useful as biomarkers for asthma diagnosis and asthma severity-risk stratification. The objective of this systematic review is to identify panels of miRNAs that can be used to support asthma...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine 2022-03, Vol.12 (4), p.543
Main Authors: Kyyaly, Mohammed Aref, Vorobeva, Elena Vladimirovna, Kothalawala, Dilini M, Fong, Wei Chern Gavin, He, Peijun, Sones, Collin L, Al-Zahrani, Mohammad, Sanchez-Elsner, Tilman, Arshad, Syed Hasan, Kurukulaaratchy, Ramesh J
Format: Article
Language:English
Subjects:
Animal models
Asthma
Bias
Biomarkers
Body fluids
Chronic obstructive pulmonary disease
Diagnosis
Lavage
MicroRNAs
miRNA
Precision medicine
Rhinitis
Risk assessment
Steroids
Systematic Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Micro RNAs (miRNAs) are short, non-coding RNAs (Ribonucleic acids) with regulatory functions that could prove useful as biomarkers for asthma diagnosis and asthma severity-risk stratification. The objective of this systematic review is to identify panels of miRNAs that can be used to support asthma diagnosis and severity-risk assessment. Three databases (Medline, Embase, and SCOPUS) were searched up to 15 September 2020 to identify studies reporting differential expression of specific miRNAs in the tissues of adults and children with asthma. Studies reporting miRNAs associations in animal models that were also studied in humans were included in this review. We identified 75 studies that met our search criteria. Of these, 66 studies reported more than 200 miRNAs that are differentially expressed in asthma patients when compared to non-asthmatic controls. In addition, 16 studies reported 17 miRNAs that are differentially expressed with differences in asthma severity. We were able to construct two panels of miRNAs that are expressed in blood and can serve as core panels to further investigate the practicality and efficiency of using miRNAs as non-invasive biomarkers for asthma diagnosis and severity-risk assessment, respectively.
ISSN:2075-4426
2075-4426
DOI:10.3390/jpm12040543